Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 178,349 | 149,135 | 53,681 | 256,492 | 206,838 |
| Depreciation Amortization | 78,731 | 53,659 | 26,813 | 98,597 | 74,022 |
| Income taxes - deferred | 1,542 | 5,212 | 16 | 4,988 | -9,146 |
| Accounts receivable | 1,489 | -104,083 | -82,956 | -18,463 | 15,234 |
| Other Working Capital | -38,091 | -128,637 | -56,548 | -17,012 | -23,807 |
| Other Operating Activity | 92,747 | 172,019 | 113,793 | 147,596 | 86,226 |
| Operating Cash Flow | $314,767 | $147,305 | $54,799 | $472,198 | $349,367 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 0 | N/A | 15,911 | 15,911 |
| PPE Investments | -28,681 | -13,690 | -4,628 | -36,348 | -20,104 |
| Net Acquisitions | N/A | N/A | N/A | -1,362 | -1,362 |
| Purchase Of Investment | N/A | N/A | N/A | -75 | N/A |
| Purchase Sale Intangibles | -25,952 | -31,152 | 5,873 | -5,593 | 0 |
| Other Investing Activity | -25,952 | -31,152 | 5,873 | 11,288 | 16,881 |
| Investing Cash Flow | $-54,633 | $-44,842 | $1,245 | $-10,586 | $11,326 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 24,685 | 15,293 | 14,253 | 43,697 | 38,420 |
| Common Stock Repurchased | -200,001 | -135,004 | -70,005 | -125,253 | -89,990 |
| Dividend Paid | -102,659 | -68,674 | -34,339 | -126,599 | -95,010 |
| Other Financing Activity | -34,753 | -33,328 | -31,743 | -39,083 | -36,603 |
| Financing Cash Flow | $-312,728 | $-221,713 | $-121,834 | $-247,238 | $-183,183 |
| Exchange Rate Effect | -1,881 | -306 | -5 | 1,235 | 1,302 |
| Beginning Cash Position | 793,361 | 793,361 | 793,361 | 577,752 | 577,752 |
| End Cash Position | 738,886 | 673,805 | 727,566 | 793,361 | 756,564 |
| Net Cash Flow | $-54,475 | $-119,556 | $-65,795 | $215,609 | $178,812 |
| Free Cash Flow | |||||
| Operating Cash Flow | 314,767 | 147,305 | 54,799 | 472,198 | 349,367 |
| Capital Expenditure | -28,681 | -13,690 | -4,628 | -36,348 | -20,104 |
| Free Cash Flow | 286,086 | 133,615 | 50,171 | 435,850 | 329,263 |